Tropical Fungal Infections

Infectious Disease Clinics of North America

Volumn 26, Issue 2, 2012, Pages 497-512

  Hsu, Li Yang ^a   Wijaya, Limin ^b   Shu Ting Ng, Esther ^a   Gotuzzo, Eduardo ^c  

^a NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

^c INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

Author keywords

Antifungal therapy; Dimorphic fungi; Epidemiology; Returning travelers; Tropical fungal infections

Indexed keywords

ALLYLAMINE; ANTIFUNGAL AGENT; BENZOIC ACID; CICLOPIROXOLAMINE; CLOFAZIMINE; FLUCONAZOLE; GRISEOFULVIN; HYPOCHLORITE SODIUM; IMIDAZOLE; ITRACONAZOLE; KERATOLYTIC AGENT; KETOCONAZOLE; POSACONAZOLE; POTASSIUM IODIDE; PROPYLENE GLYCOL; PYRROLE; SALICYLIC ACID; TERBINAFINE; VORICONAZOLE; WHITFIELD OINTMENT;

ANTIFUNGAL SUSCEPTIBILITY; BLACK PIEDRA; CHROMOMYCOSIS; DERMATOMYCOSIS; DERMATOPHYTOSIS; DRUG EFFECT; EUMYCETOMA; FUNGUS TRANSMISSION; GEOGRAPHIC DISTRIBUTION; HAIR DISEASE; HUMAN; HYPERTHERMIC THERAPY; INFECTION RISK; LOBOMYCOSIS; MYCOSIS; NONHUMAN; ONYCHOMYCOSIS; RECURRENT INFECTION; REVIEW; RISK ASSESSMENT; SPOROTRICHOSIS; SUBCUTANEOUS MYCOSIS; SUPERFICIAL MYCOSIS; SYSTEMIC THERAPY; TINEA CAPITIS; TINEA CORPORIS; TINEA CRURIS; TINEA IMBRICATA; TINEA NIGRA; TINEA PEDIS; TINEA VERSICOLOR; TRAVEL; TREATMENT DURATION; TROPICAL DISEASE; WHITE PIEDRA;

DERMATOMYCOSES; HUMANS; MYCOSES; TRAVEL; TROPICAL CLIMATE;

EID: 84861476718     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2012.02.004     Document Type: Review

References (92)

1. Hay R.J. Fungal infections. Manson's tropical diseases 2008, 1169-1189. WB Saunders, Philadelphia, Chapter 71. 22nd edition. G.C. Cook, A. Zumla (Eds.).
2. International Organization for Migration. World migration report 2010. Available at: Accessed August 13, 2011. http://publications.iom.int/bookstore/free/WMR2010_summary.pdf.
3. World Tourism Organization. Historical perspective of world tourism. Available at: Accessed August 13, 2011. http://www.unwto.org/facts/eng/historical.htm.
4. Freedman D.O., Weld L.H., Kozarsky P.E., et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006, 354:119-130.
5. Walsh T.J., Dixon D.M. Spectrum of Mycoses. Medical microbiology 1996, The University of Texas Medical Branch, Galveston (TX), Chapter 75. Available at:, Accessed February 29, 2012. http://www.ncbi.nlm.nih.gov/books/NBK7902/, 4th edition. S. Baron (Ed.).
6. Hsu L.Y., Ng E.S., Koh L.P. Common and emerging fungal pulmonary infections. Infect Dis Clin North Am 2010, 24:557-577.
7. Chakrabarti A., Slavin M.A. Endemic fungal infections in the Asia-Pacific region. Med Mycol 2011, 49:337-344.
8. Colombo A.L., Tobon A., Restrepo A., et al. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol 2011, 49:785-798.
9. Havlickova B., Czaika V.A., Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008, 51(Suppl 4):2-15.
10. Gupta A.K., Batra R., Bluhm R., et al. Pityriasis versicolor. Dermatol Clin 2003, 21:413-429.
11. Padilla-Desgarenes M.C. Pityriasis versicolor. Dermatologia Rev Mex 2005, 49:157-167.
12. Bonifaz A., Gomez-Daza F., Paredes V., et al. Tinea versicolor, tinea nigra, white piedra, and black piedra. Dermatol Clin 2010, 28:140-145.
13. Perez C., Colella M.T., Olaizola C., et al. Tinea nigra: report of twelve cases in Venezuela. Mycopathologia 2005, 160:235-238.
14. Xavier M.H., Ribeiro L.H., Duarte H., et al. Dermatoscopy in the diagnosis of tinea nigra. Dermatol Online J 2008, 14:15.
15. Ameen M. Epidemiology of superficial fungal infections. Dermatol Clin 2010, 28:197-201.
16. Millikan L.E. Current concepts in systemic and topical therapy for superficial mycoses. Dermatol Clin 2010, 28:212-216.
17. Ilkit M. Favus of the scalp: an overview and update. Mycopathologia 2010, 170:143-154.
18. Bonifaz A., Vázquez-González D. Tinea imbricate in the Americas. Curr Opin Infect Dis 2011, 24:106-111.
19. Silva J.P., de Souza W., Rozenthal S. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic region (Brazil). Mycopathologia 1998, 143:171-175.
20. Nakausavariya P., Chaiprasert A., Sivayathorn A., et al. Deep fungal and higher bacterial skin infections in Thailand: clinical manifestations and treatment regimens. Int J Dermatol 1999, 38:279-284.
21. Lupi O., Tyring S.K., McGinnis M.R. Tropical dermatology: fungal tropical diseases. J Am Acad Dermatol 2005, 53:931-951.
22. Sharma A., Hazarika N.K., Gupta D. Chromoblastomycosis in sub-tropical regions of India. Mycopathologia 2010, 169:381-386.
23. Queiroz-Telles F., McGinnis M.R., Salkin I. Subcutaneous mycoses. Infect Dis Clin North Am 2003, 17:59-85.
24. Torres E., Lievanos Z. Chromoblastomycosis associated with a lethal squamous cell carcinoma. An Bras Dermatol 2010, 85:267-270.
25. Ameen M. Managing chromoblastomycosis. Trop Doct 2010, 40:65-67.
26. Bonifaz A., Paredes-Solis V., Saul A. Treating chromoblastomycosis with systemic antifungals. Expert Opin Pharmacother 2004, 5:247-254.
27. Castro L.G., Pimental E.R., Lacaz C.S. Treatment of chromomycosis by cryosurgery with liquid nitrogen: 15 years' experience. Int J Dermatol 2003, 42:408-412.
28. Kikuchi Y., Kondo M., Yaguchi H., et al. Nihon Ishinkin Gakkai Zasshi 2007, 48:85-89. [in Japanese].
29. Negroni R., Tobon A., Bustamante B., et al. Posaconazole treatment of refractory eumycetoma and chromoblastomycosis. Rev Inst Med Trop Sao Paulo 2005, 47:339-346.
30. Sran H.S., Narula I.M., Agarwal R.K., et al. History of mycetoma. Indian J Hist Med 1972, 17:1-7.
31. Granica M., Nucci M., Queiroz-Telles F. Difficult mycoses of the skin: advances in the epidemiology and management of eumycetoma, phaeohyphomycosis and chromoblastomycosis. Curr Opin Infect Dis 2009, 22:559-563.
32. Maslin J., Morand J.J., Civatte M. The eumycetomas (fungal mycetomas with black or white grains). Med Trop (Mars) 2001, 61:111-114.
33. Ahmed A.O., van Leeuwen W., Fahal A., et al. Mycetoma caused by Madurella mycetomatis: a neglected infectious burden. Lancet Infect Dis 2004, 4:566-574.
34. Sarris I., Berendt A.R., Athanasous N., et al. MRI of mycetoma of the foot: two cases demonstrating the dot-in-circle sign. Skeletal Radiol 2003, 32:179-183.
35. Afroz N., Khan N., Siddiqui F.A., et al. Eumycetoma versus actinomycetoma: diagnosis on cytology. J Cytol 2010, 27:133-135.
36. Ahmed A.O., Desplaces N., Leonard P., et al. Molecular detection and identification of agents of eumycetoma: detailed report of two cases. J Clin Microbiol 2003, 41:5813-5816.
37. Djeng M.T., Sy M.H., Diop B.M., et al. Mycetoma: 130 cases. Ann Dermatol Venereol 2003, 130:16-19.
38. Fahal A.H., Hassan M.A. Mycetoma. Br J Surg 1992, 79:1138-1141.
39. Lobo J. Um caso de blastomicose produzido por uma especie nova encontrada em Recife. Rev Med Pernambucana 1931, 1:763-775. [in Portugese].
40. Vilela R., Mendoza L., Rosa P.S., et al. Molecular model for studying the uncultivated fungal pathogen Lacazia loboi. J Clin Microbiol 2005, 43:3657-3661.
41. Haubold E.M., Cooper C.R., Wen J.W., et al. Comparative morphology of Lacazia loboi (syn. Loboa loboi) in dolphins and humans. Med Mycol 2000, 38:9-14.
42. Burns R.A., Roy J.S., Woods C., et al. Report of the first human case of lobomycosis in the United States. J Clin Microbiol 2000, 38:1283-1285.
43. Ramos-E-Silva M., Aguiar-Santos-Vilela F., Cardoso-de-Brito A., et al. Literature review and future perspectives. Actas Dermosifiliogr 2009, 100(Suppl 1):92-100.
44. Camargo Z.P., Baruzzi R.G., Maeda S.M., et al. Antigenic relationship between Loboa loboi and Paracoccidiodes brasiliensis as shown by serological methods. Med Mycol 1998, 36:413-417.
45. Fischer M., Chrusciak Talhari A., Reinel D., et al. Successful treatment with clofazimine and itraconazole in a 46 year old patient after 32 years duration of disease. Hautarzt 2002, 53:677-681.
46. Carneiro F.P., Maia L.B., Moraes M.A., et al. Lobomycosis: diagnosis and management of relapsed and multifocal lesions. Diagn Microbiol Infect Dis 2009, 65:62-64.
47. Bustamente B., Campos P.E. Endemic sporotrichosis. Curr Opin Infect Dis 2001, 14:145-149.
48. López-Romero E., Reyes-Montes Mdel R., Pérez-Torres A., et al. Sporothrix schenckii complex and sporotrichosis, an emerging health problem. Future Microbiol 2011, 6:85-102.
49. Hay R.J., Morris-Jones R. Outbreaks of sporotrichosis. Curr Opin Infect Dis 2008, 21:119-121.
50. Kauffman C.A., Bustamante B., Chapman S.W., et al. Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007, 45:1255-1265.
51. Kohler A., Weber L., Gall H., et al. Sporotrichosis-fixed cutaneous and lymphocutaneous form. Hautarzt 2000, 51:9-12.
52. De Araujo T., Marques A.C., Kerdel F. Sporotrichosis. Int J Dermatol 2001, 40:737-742.
53. Schwendiman M.N., Johnson R.P., Henning J.S. Subcutaneous nodules with sporotrichoid spread. Dermatol Online J 2009, 15:11.
54. Maslin J., Morand J.J., Civatte M. Sporotrichosis. Med Trop (Mars) 2002, 62:9-11.
55. Mendoza M., Diaz A.M., Hung M.B., et al. Production of culture filtrates of Sporothrix schenckii in diverse culture media. Med Mycol 2002, 40:447-454.
56. Bernardes-Engemann A.R., Costa R.C., Miguens B.R., et al. Development of an enzyme-linked immunosorbent assay for the serodiagnosis of several clinical forms of sporotrichosis. Med Mycol 2005, 43:487-493.
57. Hu S., Chung W.H., Hung S.I., et al. Detection of Sporothrix schenckii in clinical samples by a nested PCR assay. J Clin Microbiol 2003, 41:1414-1418.
58. Francesconi G., Francesconi do Valle A.C., Passos S.L., et al. Comparative study of 250 mg/day terbinafine and 100 mg/day itraconazole for the treatment of cutaneous sporotrichosis. Mycopathologia 2011, 171:349-354.
59. Lederman E.R., Weld L.H., Elyazar I.R., et al. Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network. Int J Infect Dis 2008, 12:593-602.
60. Herbinger K.H., Siess C., Nothdurft H.D., et al. Skin disorders among travellers returning from tropical and non-tropical countries consulting a travel medicine clinic. Trop Med Int Health 2011, 16:1457-1464.
61. Ansart S., Perez L., Jaureguiberry S., et al. Spectrum of dermatoses in 165 travelers returning from the tropics with skin diseases. Am J Trop Med Hyg 2007, 76:184-186.
62. Lyon G.M., Bravo A.V., Espino A., et al. Histoplasmosis associated with exploring a bat-inhabited cave in Costa Rica, 1998-1999. Am J Trop Med Hyg 2004, 70:438-442.
63. Centers for Disease Control and Prevention Outbreak of histoplasmosis among travelers returning from El Salvador-Pennsylvania and Virginia, 2008. MMWR Morb Mortal Wkly Rep 2008, 57:1349-1353.
64. Nasta P., Donisi A., Cattane A., et al. Acute histoplasmosis in spelunkers returning from Mato Grosso, Peru. J Travel Med 1997, 4:176-178.
65. Valdez H., Salata R.A. Bat-associated histoplasmosis in returning travelers: case presentation and description of a cluster. J Travel Med 1999, 6:258-260.
66. Salomon J., Flament Saillour M., De Truchis P., et al. An outbreak of acute pulmonary histoplasmosis in members of a trekking trip in Martinique, French West Indies. J Travel Med 2003, 10:87-93.
67. Gascon J., Torres J.M., Luburich P., et al. Imported histoplasmosis in Spain. J Travel Med 2000, 7:89-91.
68. Ohno H., Ogata Y., Suguro H., et al. An outbreak of histoplasmosis among healthy young Japanese women after traveling to Southeast Asia. Intern Med 2010, 49:491-495.
69. Weinberg M., Weeks J., Lance-Parker S., et al. Severe histoplasmosis in travelers to Nicaragua. Emerg Infect Dis 2003, 9:1322-1325.
70. Norman F.F., Martin-Davila P., Fortun J., et al. Imported histoplasmosis: two distinct profiles in travelers and immigrants. J Travel Med 2009, 16:258-262.
71. Buitrago M.J., Bernal-Martinez L., Castelli M.V., et al. Histoplasmosis and paracoccidioidomycosis in a non-endemic area: a review of cases and diagnosis. J Travel Med 2011, 18:26-33.
72. Rosenstein N.E., Emery K.W., Werner S.B., et al. Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis 2001, 32:708-715.
73. Cairns L., Blythe D., Kao A., et al. Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis 2000, 30:61-64.
74. Centers for Disease Control and Prevention Coccidioidomycosis in travelers returning from Mexico-Pennsylvania, 2000. MMWR Morb Mortal Wkly Rep 2000, 49:1004-1006.
75. Ogiso A., Ito M., Koyama M., et al. Pulmonary coccidioidomycosis in Japan: case report and review. Clin Infect Dis 1997, 25:1260-1261.
76. Kumar K.S., Narasimhan A., Gopalakrishnan R., et al. Coccidioidomycosis in Chennai. J Assoc Physicians India 2011, 59:122-124.
77. Bharucha N.E., Ramamoorthy K., Sorabjee J., et al. All that caseates is not tuberculosis. Lancet 1996, 348:1313.
78. Verghese S., Arjundas D., Krishnakumar K.C., et al. Coccidioidomycosis in India: report of a second imported case. Med Mycol 2002, 40:307-309.
79. Centers for Disease Control and Prevention Coccidioidomycosis among persons attending the world championship of model airplane flying-Kern County, California, October 2001. MMWR Morb Mortal Wkly Rep 2001, 50:1106-1107.
80. Sirisanthana T., Supparatpinyo K. Epidemiology and management of penicilliosis in human immunodeficiency virus-infected patients. Int J Infect Dis 1998, 3:48-53.
81. Perlman D.C., Carey J. Prevention of disseminated Penicillium marneffei in human immunodeficiency virus-infected travelers. J Travel Med 2006, 13:386.
82. Antinori S., Gianelli E., Bonaccorso C., et al. Disseminated Penicillium marneffei infection in an HIV-positive Italian patient and a review of cases reported outside endemic regions. J Travel Med 2006, 13:181-188.
83. Carey J., Hofflich H., Amre R., et al. Penicillium marneffei infection in an immunocompromised traveler: a case report and literature review. J Travel Med 2005, 12:291-294.
84. Lo Y., Tintelnot K., Lippert U., et al. Disseminated Penicillium marneffei infection in an African AIDS patient. Trans R Soc Trop Med Hyg 2000, 94:187.
85. Ginarte M., Pereiro M., Toribio J. Imported paracoccidioidomycosis in Spain. Mycoses 2003, 46:407-411.
86. Horre R., Schumacher G., Alpers K., et al. A case of imported paracoccidioidomycosis in a German legionnaire. Med Mycol 2002, 40:213-216.
87. Van Damme P.A., Bierenbroodspot F., Telgtt D.S., et al. A case of imported paracoccidioidomycosis: an awkward infection in The Netherlands. Med Mycol 2006, 44:13-18.
88. Hagen F., van Assen S., Luijckx G.J., et al. Activated dormant Cryptococcus gattii infection in a Dutch tourist who visited Vancouver Island (Canada): a molecular epidemiological approach. Med Mycol 2010, 48:528-531.
89. Georgi A., Schneemann M., Tintelnot K., et al. Cryptococcus gattii meningoencephalitis in an immunocompetent person 13 months after exposure. Infection 2009, 37:370-373.
90. Datta K., Bartlett K.H., Baer R., et al. Spread of Cryptococcus gattii into Pacific Northwest region of the United States. Emerg Infect Dis 2009, 15:1185-1191.
91. Velazquez R., Munoz-Hernandez B., Arenas R., et al. An imported case of Blastomyces dermatitidis infection in Mexico. Mycopathologia 2003, 156:263-267.
92. Rodriguez-Mena A., Mayorga J., Solis-Ledesma G., et al. Rev Iberoam Micol 2010, 27:210-212. [in Spanish].